CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events
CK20-004,杜克大学-北卡罗来纳大学预防震中计划,旨在保护患者免受感染、抗生素耐药性和其他不良事件的影响
基本信息
- 批准号:10404899
- 负责人:
- 金额:$ 167.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
Healthcare-associated infections (HAIs) and antimicrobial resistance (AR) lead to adverse patient outcomes,
including increased mortality, morbidity, and length of hospitalization. While progress in prevention is occurring,
innovative and improved strategies for prevention of HAIs, AR, and patient harm are needed. The overall
objective of this proposal is to identify potential strategies to decrease HAIs and prevent AR emergence,
transmission, and acquisition. Our Core Proposal includes 6 unique studies to address 4 specific lines of
investigation (specific aims [SA]): environmental disinfection, antimicrobial stewardship, diagnostic stewardship,
and community-acquired Clostridioides difficile infection (CA-CDI). These studies will 1) evaluate novel
strategies to decrease environmental contamination with opportunistic premise plumbing pathogens related to
hospital sinks using a) Pall filters and drain covers (SA1A) and b) engineered plasmids (SA1B); 2) identify and
evaluate innovative antimicrobial stewardship (AS) interventions and metrics to decrease AR and patient harm
a) at transitions of care (e.g., discharge) in community hospitals (SA2A) and b) related to post-operative
antibiotics (SA2B); 3) develop and validate reflex urine culture criteria to guide improved utilization of urine
cultures (SA3); and 4) evaluate and determine the contribution of environmental sources on acquisition and
occurrence of CA-CDI (SA4). These studies involve patients admitted to community and academic hospitals as
well as patients in the community setting. We will achieve this objective by using the strengths of a unique,
innovative, and previously successful collaboration between investigators in the Duke Center for Antimicrobial
Stewardship and Infection Prevention and the University of North Carolina at Chapel Hill. We will capitalize on
programmatic strengths in both institutions: expertise in environmental disinfection, antimicrobial stewardship,
infection prevention, AR, epidemiology, surveillance, and emerging infections; access to large and unique
research networks and infrastructure; and proven success with collaborative research involving multiple
institutions. All Core Projects proposed in this application represent early stage translational research (T0-T1)
with clearly identified “next steps” that will help expedite identification and development of practices that
effectively prevent HAIs and AR. In addition, we are proposing 3 Collaborative Projects with other CDC
Prevention Epicenters Programs: 1) a cluster randomized non-inferiority crossover trial on the use of contact
precautions for MRSA and VRE acquisition (Large); 2) evaluation of the feasibility and utility of robust antibiotic
use risk-adjustment machine learning models (Medium); and 3) metagenomic evaluation to determine if and how
often endogenous flora contaminate surgical wounds (Small). These studies involve patients admitted to
community and academic hospitals. Overall, these studies exemplify our ongoing collaboration between
scientists with expertise in T0 metagenomics, bioengineering, and microbiology and researchers with expertise
in T1-T2 studies. The contribution of these studies will be significant because they will lead to new strategies to
prevent HAIs, AR, and patient harm, thereby improving the health and safety of the US population.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deverick John Anderson其他文献
Deverick John Anderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deverick John Anderson', 18)}}的其他基金
CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events
CK20-004,杜克大学-北卡罗来纳大学预防震中计划,旨在保护患者免受感染、抗生素耐药性和其他不良事件的影响
- 批准号:
10650205 - 财政年份:2021
- 资助金额:
$ 167.43万 - 项目类别:
CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events
CK20-004,杜克大学-北卡罗来纳大学预防震中计划,旨在保护患者免受感染、抗生素耐药性和其他不良事件的影响
- 批准号:
10466727 - 财政年份:2021
- 资助金额:
$ 167.43万 - 项目类别:
Duke-UNC Prevention Epicenter Program for Prevention of Healthcare-Associated Infections
杜克大学-北卡罗来纳大学预防医疗保健相关感染的预防震中计划
- 批准号:
10192601 - 财政年份:2016
- 资助金额:
$ 167.43万 - 项目类别:
Prevention of Surgical Site Infection using Statistical Process Control Charts
使用统计过程控制图预防手术部位感染
- 批准号:
9302308 - 财政年份:2015
- 资助金额:
$ 167.43万 - 项目类别:
Prevention of Surgical Site Infection using Statistical Process Control Charts
使用统计过程控制图预防手术部位感染
- 批准号:
9027975 - 财政年份:2015
- 资助金额:
$ 167.43万 - 项目类别:
Prevention of Surgical Site Infection using Statistical Process Control Charts
使用统计过程控制图预防手术部位感染
- 批准号:
9134047 - 财政年份:2015
- 资助金额:
$ 167.43万 - 项目类别:
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi
社区多重耐药菌的临床和分子流行病学
- 批准号:
8500164 - 财政年份:2011
- 资助金额:
$ 167.43万 - 项目类别:
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi
社区多重耐药菌的临床和分子流行病学
- 批准号:
8298965 - 财政年份:2011
- 资助金额:
$ 167.43万 - 项目类别:
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi
社区多重耐药菌的临床和分子流行病学
- 批准号:
8687578 - 财政年份:2011
- 资助金额:
$ 167.43万 - 项目类别:
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi
社区多重耐药菌的临床和分子流行病学
- 批准号:
8165486 - 财政年份:2011
- 资助金额:
$ 167.43万 - 项目类别:
相似国自然基金
新型蒽酚类化合物XYD004通过激活AHR缓解银屑病的作用及机制研究
- 批准号:2025JJ60573
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
tiRNA-Val-TAC-004在胃癌进展中的作用机制及标志物价值研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
环状RNA hsa_circSERPINE2_004介导MSC衰老在老年性骨质 疏松症发病中的作用及其机制研究
- 批准号:
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
ADRQβ-004疫苗靶向α1D-AR调节交感神经失衡与改善肺动脉重构的机制研究
- 批准号:82070522
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
CsERF004调控黄瓜双抗性分子机制的研究
- 批准号:31801871
- 批准年份:2018
- 资助金额:27.0 万元
- 项目类别:青年科学基金项目
Snail/p53结合抑制剂SN004的抗肿瘤作用及分子机制研究
- 批准号:81803033
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
SMIP004/SMIP004-7系列线粒体抑制剂作用机制及应用于去势抵抗性前列腺癌治疗的潜力研究
- 批准号:81773771
- 批准年份:2017
- 资助金额:58.0 万元
- 项目类别:面上项目
以CKLF1为新型药物靶标的发现及其抗缺血性损伤的系统性药理学研究
- 批准号:81730096
- 批准年份:2017
- 资助金额:290.0 万元
- 项目类别:重点项目
新型脑保护剂H004及其活性葡萄糖醛酸代谢产物的脑转运代谢机制及药代-药效学研究
- 批准号:81603190
- 批准年份:2016
- 资助金额:17.3 万元
- 项目类别:青年科学基金项目
木质纤维素水解液中抑制剂对发酵性丝孢酵母T.fermentans HWZ004细胞生长和油脂积累的影响规律及其机理研究
- 批准号:31071559
- 批准年份:2010
- 资助金额:36.0 万元
- 项目类别:面上项目
相似海外基金
RFA-PS-23-004, Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home (INVITE-Home)
RFA-PS-23-004,长效注射剂的创新管理,用于在家加强艾滋病毒治疗(INVITE-Home)
- 批准号:
10795542 - 财政年份:2023
- 资助金额:
$ 167.43万 - 项目类别:
CE-22-004 Research Grants to Prevent Firearm-Related Violence and Injuries (R01) - 2022
CE-22-004 预防枪支相关暴力和伤害的研究资助 (R01) - 2022
- 批准号:
10907151 - 财政年份:2023
- 资助金额:
$ 167.43万 - 项目类别:
RFA-CE-22-004, Firearm Violence Perpetration: A Nationally Representative Multi-Wave Survey of Youth and Young Adults Across the United States
RFA-CE-22-004,枪支暴力犯罪:对美国青少年和年轻人进行的具有全国代表性的多轮调查
- 批准号:
10894584 - 财政年份:2022
- 资助金额:
$ 167.43万 - 项目类别:
RFA-IP-22-004, US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings
RFA-IP-22-004,衡量季节性流感、COVID-19 和其他呼吸道病毒疫苗在流动环境中预防急性疾病有效性的美国平台
- 批准号:
10808975 - 财政年份:2022
- 资助金额:
$ 167.43万 - 项目类别:
GH21-004, COVID-19 and related public health threats in populations affected by crises: a multi-disciplinary, collaborative research programme
GH21-004、COVID-19 和受危机影响人群的相关公共卫生威胁:多学科合作研究计划
- 批准号:
10782556 - 财政年份:2022
- 资助金额:
$ 167.43万 - 项目类别:
RFA-IP-22-004, Multidisciplinary Approach to Understanding Vaccine Efficacy and Transmission of Viral Respiratory Tract Infections in the Real World
RFA-IP-22-004,了解疫苗功效和现实世界中病毒呼吸道感染传播的多学科方法
- 批准号:
10703257 - 财政年份:2022
- 资助金额:
$ 167.43万 - 项目类别:
RFA-CE-22-004, Optimizing Firearm Suicide Prevention in Healthcare
RFA-CE-22-004,优化医疗保健中的枪支自杀预防
- 批准号:
10558911 - 财政年份:2022
- 资助金额:
$ 167.43万 - 项目类别:
RFA-CE-22-004, Understanding personal, social network, and neighborhood environmental contributors to firearm access and violence among young adults experiencing homelessness
RFA-CE-22-004,了解个人、社交网络和社区环境对无家可归的年轻人获取枪支和暴力的影响因素
- 批准号:
10560370 - 财政年份:2022
- 资助金额:
$ 167.43万 - 项目类别:
GH21-004, COVID-19 and related public health threats in populations affected by crises: a multi-disciplinary, collaborative research programme
GH21-004、COVID-19 和受危机影响人群的相关公共卫生威胁:多学科合作研究计划
- 批准号:
10355552 - 财政年份:2022
- 资助金额:
$ 167.43万 - 项目类别: